While here, she recieved 3units pRBCs and her hct stabilized.
Her head bleed stabilized with platelets.
In the ED, initial vitals were T 100.0, BP 150/89, HR 140, RR 16, O2 sat 99%.
She has generalized weakness, no chills, no cough, dysuea, abdominal pain, rhinorrhea, cold symptoms, n/v/d.
Pertinent Results: ADMISSION LABS: [**2106-4-8**] 05:26AM BLOOD WBC-0.3* RBC-3.00* Hgb-9.0* Hct-25.8* MCV-86 MCH-30.0 MCHC-34.8 RDW-13.3 Plt Ct-31* [**2106-4-8**] 05:26AM BLOOD Neuts-64 Bands-0 Lymphs-32 Monos-0 Eos-4 Baso-0 Atyps-0 Metas-0 Myelos-0 [**2106-4-9**] 09:10PM BLOOD ESR-68* [**2106-4-8**] 05:26AM BLOOD Glucose-113* UreaN-29* Creat-0.7 Na-141 K-3.3 Cl-104 HCO3-31 AnGap-9 [**2106-4-8**] 05:26AM BLOOD Calcium-8.3* Phos-3.1 Mg-1.8 [**2106-4-9**] 09:07PM BLOOD Lactate-1.0 [**2106-4-9**] 09:10PM URINE RBC-0 WBC-0 Bacteri-NONE Yeast-NONE Epi-0 [**2106-4-9**] 09:10PM URINE Blood-TR Nitrite-NEG Protein-75 Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-NEG .
CXR ON [**2106-4-22**]: SINGLE PORTABLE CHEST RADIOGRAPH: Moderate-to-large bilateral pleural effusions with compressive atelectasis are persistent, with increase in size on the right.
CT OF CHEST/ABD AND PELVIS ON [**2106-4-13**]: CT CHEST: Moderate bilateral pleural effusions have increased in size since the previous examination.
ECG ON [**2106-4-9**]: Atrial fibrillation with rapid ventricular response.
Rate PR QRS QT/QTc P QRS T 134 0 68 292/421 0 0 173 .
DISCHARGE LABS: [**2106-5-4**] 00:45 COMPLETE BLOOD COUNT WBC RBC    Hgb  Hct    MCV  MCH   MCHC RDW  Plt Ct [**2106-5-4**] 00:45     4.0  2.90*  8.2* 24.7*   85  28.4  33.3 14.2  21* Source: Line-PICC   DIFFERENTIAL Neuts 68%  Bands 6% Lymphs 8* Monos 14* Eos 0 Baso 0 Atyps 2Metas 2 Myelos 0   Source: Line-PICC   BASIC COAGULATION:  PT 13.8* PTT 29.2 INR(PT)  1.2*   ANC:  3063  CHEMISTRY: RENAL & GLUCOSE     Glucose UreaN  Creat Na   K    Cl  HCO3 AnGap [**2106-5-4**] 00:45    111*1    29*   1.1   139  3.9  97  35*   11     ENZYMES & BILIRUBIN  ALT  AST     LD(LDH) TotBili [**2106-5-4**] 00:45     27   44*     176*     1.3                       Calcium Phos   Mg [**2106-5-4**] 00:45    9.1     4.0    1.8 Source: Line-PICC .
**FINAL REPORT [**2106-4-17**]**     URINE CULTURE (Final [**2106-4-17**]):    NO GROWTH.
**FINAL REPORT [**2106-4-13**]**     URINE CULTURE (Final [**2106-4-13**]):       GRAM POSITIVE BACTERIA.
Blood Culture, Routine (Final [**2106-4-18**]):    NO GROWTH.
Blood Culture, Routine (Final [**2106-4-19**]):       PSEUDOMONAS AERUGINOSA.
Tigecycline = 32 MCG/ML (NO INTERPRETATION).
Sensitivity testing performed by Etest.
UNASYN (AMPICILLIN/SULBACTAM) = 6MM (NO ZONE, NO INTERPRETATION).
sensitivity testing performed by [**First Name8 (NamePattern2) 3077**] [**Last Name (NamePattern1) 3060**].
SENSITIVITIES: MIC expressed in MCG/ML  _________________________________________________________                              PSEUDOMONAS AERUGINOSA                              | CEFEPIME--------------    32 R CEFTAZIDIME-----------    32 R CIPROFLOXACIN---------   =>4 R GENTAMICIN------------     8 I MEROPENEM-------------     8 I PIPERACILLIN/TAZO----- =>128 R TOBRAMYCIN------------     2 S     Aerobic Bottle Gram Stain (Final [**2106-4-10**]):       REPORTED BY PHONE TO [**First Name8 (NamePattern2) 4617**] [**Last Name (NamePattern1) **] @ 2207 ON [**4-10**] - [**Numeric Identifier 6026**].
**FINAL REPORT [**2106-4-20**]**     CLOSTRIDIUM DIFFICILE TOXIN A & B TEST (Final [**2106-4-11**]):       REPORTED BY PHONE TO [**Doctor First Name **] [**Doctor Last Name 78635**] (4I) [**2106-4-11**] AT 1500.
Brief Hospital Course: # Pseudomonas bacteremia - Blood cultures were positive for multi drug resistant Pseudomonas aeruginosa.
She was discharged on 40mg of PO lasix with additional IV lasix given with blood products.
She was tranfused PRBC to Hct of 25, and platelets of 10.
She was treated with cyclosporine, and her dose was titrated to a therapeutic serum level of ~200.
She will need to continue to have the cyclosporine levels checked during her oncology office visits.
Her last PRBCs transfusion was on [**2106-5-4**] for HCT of 24.7 and plalet transfusion was on [**2106-5-2**] for Plats of 8,000 for which she responded well.
# AF with RVR - On admission she was in atrial fibrillation with rapid ventricular rate in the 140s.
# Lymphoplasmacytic lymphoma  - CT torso showed no recurrance or growth of her lymphoma.
Bleed stable on CT scan after platelets.
Neurologic exam remained stable throughout her stay.
Her BP has been under good control on current regimen and this will need to be readress with her primary care doctor [**First Name (Titles) **] [**Last Name (Titles) 5564**].
# Urinary incontinence: pt with urinary incontinence and her skin was fragile due to immobility and anasarca.
Foley catheter was placed to protect her skin, and for close monitoring of output while been diuresed.
Please note the following changes in your medications: - Meropenem 1000mg IV daily - Vancomycin 125mg by mouth, four times daily - Started on lasix 40mg daily - Stopped HCTZ - Holding Amlodipine, until you further discuss with your doctor.
You will need to have blood work done daily to monitor your blood counts and to have transfusion of PRBC for Hct less than 25 and plalets less than 10,000.
You will also need to have blood draws to monitor your electrolytes including magnesium and potassium.
Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 7779**], MD Date/Time:[**2106-5-13**] 12:00, [**Hospital1 **], [**Hospital Ward Name **] BUILDING LEVEL 9 Phone:[**Telephone/Fax (1) 3241**]
